See the DrugPatentWatch profile for ozempic

Ozempic, a medication used to improve blood sugar control in adults with type 2 diabetes, is typically administered via subcutaneous injection once weekly. The dosage may vary depending on the patient's individual needs and the prescription provided by their healthcare professional. It is important to follow the specific dosage instructions provided by a healthcare provider.

For more information on Ozempic and its administration, please refer to the following sources:

1. "Ozempic (semaglutide) injection, for subcutaneous use." DailyMed. <https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=48d3e8e2-9e3e-4e2f-a2b1-61a8a9a9a1b5&type=display>.
2. "Semaglutide." DrugPatentWatch. <https://www.drugpatentwatch.com/drugs/semaglutide>.